BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 23641925)

  • 1. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.
    Haun F; Nakamura T; Shiu AD; Cho DH; Tsunemi T; Holland EA; La Spada AR; Lipton SA
    Antioxid Redox Signal; 2013 Oct; 19(11):1173-84. PubMed ID: 23641925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.
    Shirendeb UP; Calkins MJ; Manczak M; Anekonda V; Dufour B; McBride JL; Mao P; Reddy PH
    Hum Mol Genet; 2012 Jan; 21(2):406-20. PubMed ID: 21997870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity.
    Song W; Chen J; Petrilli A; Liot G; Klinglmayr E; Zhou Y; Poquiz P; Tjong J; Pouladi MA; Hayden MR; Masliah E; Ellisman M; Rouiller I; Schwarzenbacher R; Bossy B; Perkins G; Bossy-Wetzel E
    Nat Med; 2011 Mar; 17(3):377-82. PubMed ID: 21336284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drp1 phosphorylation by MAPK1 causes mitochondrial dysfunction in cell culture model of Huntington's disease.
    Roe AJ; Qi X
    Biochem Biophys Res Commun; 2018 Feb; 496(2):706-711. PubMed ID: 29397067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury.
    Cho DH; Nakamura T; Fang J; Cieplak P; Godzik A; Gu Z; Lipton SA
    Science; 2009 Apr; 324(5923):102-5. PubMed ID: 19342591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration.
    Nakamura T; Cieplak P; Cho DH; Godzik A; Lipton SA
    Mitochondrion; 2010 Aug; 10(5):573-8. PubMed ID: 20447471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease.
    Bossy B; Petrilli A; Klinglmayr E; Chen J; Lütz-Meindl U; Knott AB; Masliah E; Schwarzenbacher R; Bossy-Wetzel E
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S513-26. PubMed ID: 20463395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission.
    Reddy PH
    Drug Discov Today; 2014 Jul; 19(7):951-5. PubMed ID: 24681059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.
    Guo X; Disatnik MH; Monbureau M; Shamloo M; Mochly-Rosen D; Qi X
    J Clin Invest; 2013 Dec; 123(12):5371-88. PubMed ID: 24231356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.
    Manczak M; Calkins MJ; Reddy PH
    Hum Mol Genet; 2011 Jul; 20(13):2495-509. PubMed ID: 21459773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.
    Kim J; Moody JP; Edgerly CK; Bordiuk OL; Cormier K; Smith K; Beal MF; Ferrante RJ
    Hum Mol Genet; 2010 Oct; 19(20):3919-35. PubMed ID: 20660112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.
    Manczak M; Reddy PH
    Hum Mol Genet; 2012 Jun; 21(11):2538-47. PubMed ID: 22367970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation.
    Akhtar MW; Sanz-Blasco S; Dolatabadi N; Parker J; Chon K; Lee MS; Soussou W; McKercher SR; Ambasudhan R; Nakamura T; Lipton SA
    Nat Commun; 2016 Jan; 7():10242. PubMed ID: 26743041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.
    Shirendeb U; Reddy AP; Manczak M; Calkins MJ; Mao P; Tagle DA; Reddy PH
    Hum Mol Genet; 2011 Apr; 20(7):1438-55. PubMed ID: 21257639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.
    Reddy PH; Shirendeb UP
    Biochim Biophys Acta; 2012 Feb; 1822(2):101-10. PubMed ID: 22080977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease.
    Joshi AU; Ebert AE; Haileselassie B; Mochly-Rosen D
    J Mol Cell Cardiol; 2019 Feb; 127():125-133. PubMed ID: 30550751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects.
    Zhao Y; Sun X; Hu D; Prosdocimo DA; Hoppel C; Jain MK; Ramachandran R; Qi X
    Nat Commun; 2019 Mar; 10(1):1371. PubMed ID: 30914652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin.
    Damiano M; Diguet E; Malgorn C; D'Aurelio M; Galvan L; Petit F; Benhaim L; Guillermier M; Houitte D; Dufour N; Hantraye P; Canals JM; Alberch J; Delzescaux T; Déglon N; Beal MF; Brouillet E
    Hum Mol Genet; 2013 Oct; 22(19):3869-82. PubMed ID: 23720495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.
    Reddy PH; Reddy TP; Manczak M; Calkins MJ; Shirendeb U; Mao P
    Brain Res Rev; 2011 Jun; 67(1-2):103-18. PubMed ID: 21145355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of CRMP2 in Regulation of Mitochondrial Morphology and Motility in Huntington's Disease.
    Brustovetsky T; Khanna R; Brustovetsky N
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.